Bladder Cancer | Tumor

As Cases of Bladder Cancer Rise, One Organization Can Help Educate and Connect Patients

February 24th 2021, 10:00pm


To discuss the projected rise in bladder cancer cases in 2021, CURE® spoke with Bladder Cancer Advocacy Network (BCAN) co-founder Diane Zipursky-Quale, who offered some insight on why the numbers continue to rise, and provides some hope in the form of educational programs offered by her organization.

Padcev Continues to Show Promise in Patients with Previously Treated Bladder Cancer

February 15th 2021, 10:00pm


Treatment with Padcev, compared to chemotherapy, continues to show better results in patients with advanced urothelial carcinoma who had previously received certain therapies.

Bladder Cancer Matters Podcast Part 2: Why Bladder Cancer Patients May Need an Oncology Social Worker with Dr. Heather Goltz

February 15th 2021, 1:00pm


In Episode 2 of the “Bladder Cancer Matters” podcast, host Rick Bangs interviews Dr. Heather Honoré Goltz in Part 2 of a two-part episode.

Bladder Cancer Matters Podcast: Should Bladder Cancer Patients Work with an Oncology Social Worker?

February 14th 2021, 12:30pm


The Bladder Cancer Advocacy Network's new podcast by, for, and about the bladder cancer community, "Bladder Cancer Matters," has a new episode available.

BCAN's First "Bladder Cancer Matters" Podcast is Now Available

February 2nd 2021, 2:34pm


In the inaugural “Bladder Cancer Matters” podcast, host Rick Bangs interviews Dr. Ashish Kamat about the state of BCG in bladder cancer treatment. Dr. Kamat is a Professor (Tenure) of Urology and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center, and a graduate of the AUA Leadership Program. Dr. Kamat also serves on BCAN’s Scientific Advisory Board.

Announcing BCAN’s 2021 Young Investigator Award

January 30th 2021, 12:30pm


The Bladder Cancer Advocacy Network (BCAN) announced that it is accepting applications for our 2021 Young Investigator Awards (YIAs).

BCAN Announces 2021 Bladder Cancer Research Innovation Award

January 26th 2021, 12:00pm


BCAN is pleased to announce two 2021 Bladder Cancer Research Innovation Awards to support the work of investigators with exceptionally novel and creative projects with great potential to produce breakthroughs in our understanding of the management of bladder cancer.

BCAN Ranked as a Top Charity with a 4-Star Ranking for Seventh Consecutive Year

January 18th 2021, 12:00pm


The Bladder Cancer Advocacy Network’s (BCAN’s) strong financial health and commitment to accountability and transparency have earned it a seventh consecutive 4-star rating from Charity Navigator, America’s largest independent charity evaluator. This award puts BCAN in the top seven percent of all charities.

BCAN Applauds Bill to Provide Long-Overdue Help to Veteran Bladder Cancer Patients

January 11th 2021, 2:00pm


The Bladder Cancer Advocacy Network (BCAN) is pleased that the U.S. Senate voted overwhelmingly to approve the National Defense Authorization Act (NDAA) which contains a critical provision that will help veterans who were exposed to Agent Orange and later developed bladder cancer.

Higher Tumor Classification and Grade for Nonmuscle-Invasive Bladder Cancer May Increase Recurrence and Progression Risk Up to Five Years

December 1st 2020, 7:30pm


Predicting risk for recurrence and progression in patients with nonmuscle-invasive bladder cancer may help when discussing management options with clinicians.